Paul Rothhaar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paul Rothhaar has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Volker Lohmann
Department of Infectious Diseases, Molecular Virology, Section Virus-host interactions, Heidelberg University, Heidelberg, Germany
2 shared publications Aftab Ala
1 shared publication- Alexander Gabel
Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, 97080 Würzburg, Germany
1 shared publication Alina C. Schneider
Department of Infectious Diseases, Molecular Virology, Section Virus-host interactions, Heidelberg University, Heidelberg, Germany
1 shared publication- Andrew R. Lloyd
The Kirby Institute, University of New South Wales, Sydney, Australia
1 shared publication Ann Sarah Walker
1 shared publication
Latest Publications
- Open Access
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease
Hepatitis C virus (HCV) exists as a heterogenous quasispecies, but the phenotypic consequences of viral variability are widely unexplored. Here we identify a replication enhancing domain (ReED) in non-structural protein 5A conferring high replication fitness to clinical isolates. Accumulation of mutations in the ReED mediates high genome replication capacity. In a cohort of liver transplant patients, high replicator variants are exclusively found in individuals with severe disease outcome, suggesting that high viral replication fitness is associated with increased viral pathogenesis. Analysis of large sequence cohorts reveals that overall only 10% of viral genomes show genetic signatures of high replicators, which are enriched in recipients of liver transplantations, patients developing hepatocellular carcinoma and in HIV coinfected individuals. Overall, our data suggests that low replication fitness is a hallmark of HCV, contributing to establishment of persistence, whereas high replicators appear to have an advantage under conditions of immune suppression, thereby enforcing pathogenesis.
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Open AccessHighly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease
Hepatitis C virus (HCV) exists as a heterogenous quasispecies, but the phenotypic consequences of viral variability are widely unexplored. Here we identify a replication enhancing domain (ReED) in non-structural protein 5A conferring high replication fitness to clinical isolates. Accumulation of mutations in the ReED mediates high genome replication capacity. In a cohort of liver transplant patients, high replicator variants are exclusively found in individuals with severe disease outcome, suggesting that high viral replication fitness is associated with increased viral pathogenesis. Analysis of large sequence cohorts reveals that overall only 10% of viral genomes show genetic signatures of high replicators, which are enriched in recipients of liver transplantations, patients developing hepatocellular carcinoma and in HIV coinfected individuals. Overall, our data suggests that low replication fitness is a hallmark of HCV, contributing to establishment of persistence, whereas high replicators appear to have an advantage under conditions of immune suppression, thereby enforcing pathogenesis.
- Open Access
- 27 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-21
Hepatitis C virus NS3 helicase contributes to (−) strand RNA synthesis
Many positive strand RNA viruses encode helicases, but their distinct functions in viral replication cycles is poorly understood. Here, we identify a mutation in the helicase domain of HCV non-structural protein 3 (NS3h), D1467G, which specifically affects (−) strand synthesis, phenocopying mutations in the 3’ untranslated region of the genome. D1467G does not impair helicase activity in vitro or the binding of NS3h to critical cis-acting RNA elements, but reduces the interaction of NS3h and NS5B polymerase, potentially contributing to defective (−) strand synthesis. AlphaFold predictions of complexes between NS3h, RNA and/or NS5B suggest that NS3h both remodels the cis-acting RNA elements and unwinds the terminal stem-loop of the HCV genome rendering the template accessible for de novo initiation of (−) strand synthesis by NS5B. Overall, our study provides evidence for a defined function of a viral helicase in (−) strand genome synthesis of a positive strand RNA virus.
- 27 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-21
Open AccessHepatitis C virus NS3 helicase contributes to (−) strand RNA synthesis
Many positive strand RNA viruses encode helicases, but their distinct functions in viral replication cycles is poorly understood. Here, we identify a mutation in the helicase domain of HCV non-structural protein 3 (NS3h), D1467G, which specifically affects (−) strand synthesis, phenocopying mutations in the 3’ untranslated region of the genome. D1467G does not impair helicase activity in vitro or the binding of NS3h to critical cis-acting RNA elements, but reduces the interaction of NS3h and NS5B polymerase, potentially contributing to defective (−) strand synthesis. AlphaFold predictions of complexes between NS3h, RNA and/or NS5B suggest that NS3h both remodels the cis-acting RNA elements and unwinds the terminal stem-loop of the HCV genome rendering the template accessible for de novo initiation of (−) strand synthesis by NS5B. Overall, our study provides evidence for a defined function of a viral helicase in (−) strand genome synthesis of a positive strand RNA virus.